× Industry Reports Services Press Release Contact us About us

Europe Rare Sugar Market Size By Application (Dietary supplements, Cosmetics & Personal care, Pharmaceuticals, Food & Beverages, Others), By Product (D-Mannose, Allulose, Tagatose, D-Xylose, L-Arabinose, and L-Fucose), Research Report, Country Outlook, Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2020 – 2026
Published Date: March 2021 | Publisher: Graphical Research Report ID: GR1698 | Delivery : PDF  Request Free Sample

Europe Rare Sugar Market size exceeded USD 200 million in 2019 and is anticipated to register a growth rate of 3.5% between 2020 and 2026.

Rare sugars are monosaccharides that rarely occur in nature such as D-allose, D-tagatose, D-allulose, xylitol, L-ribose, etc. and can be obtained from biochemical processes such as enzymatic conversion and fermentation. Rare sugars can suppress hyperglycemia and lipid accumulation which helps in preventing diabetes and obesity. Rare sugars contain less calories that normal sugars, hence have gained popularity among consumers as substitutes for sugars and artificial sweeteners such as fructose, sucrose, and HFS.

Utilization of rare sugars has gained traction owing to rising consumer awareness on use of sugar alternatives and reducing calorie content in diets and creating lucrative growth opportunities for the Europe rare sugar industry.  

European Market, By Product

The allulose segment is predicted to register a growth of over 6.5% from 2020 to 2026. Allulose is a low-calorie rare sugar or monosaccharide that has similar characteristics that of fructose and is naturally present in fruits like raisins, jackfruits, and figs in small quantities. Moreover, allulose is also used in food applications as a sugar alternative as it replicates functional properties of sugar and has less calories.

Consumer awareness regarding health, diet, and chronic diseases has soared in recent years owing to increase in the number of individuals suffering from diabetes and obesity. The number of people suffering from diabetes was over 60 million in 2019 and the number is estimated to reach USD 65 million by the end of 2025. Rise in the number of individual suffering from diabetes is expected to boost the demand for low calorie sweeteners and projected to trigger the Europe allulose sector.

Drugs manufactured from natural sugar compounds can cause biochemical reactions during cellular processes, however, medicines produced using rare sugars do not interfere with cellular processes. Therefore, rare sugars can be of high importance in commercia synthesis of anti-cancer drugs and antiviral drugs. Rising prevalence of breast cancer, colorectal cancer, prostate cancer, and lung cancer in European countries should accelerate the demand for anti-cancer drugs, which may stimulate the utilization of rare sugars in producing anti-cancer drugs.

European Market, By Application

The demand for dietary supplements has increased in UK during the forecast period, owing to growing consumer awareness and increasing number of individuals suffering from diabetes. Consumers are adopting healthy diets and nutritional foods that contain low calorie and low sugar foods for treating and preventing chronic diseases.

Competitive Industry Landscape

Europe rare sugar market share is significantly competitive with major players including Douglas Laboratories Europe, DuPont de Nemours, Inc., Tate & Lyle, Zhangjiagang Specom Biochemical Co., Ltd., Nutraceuticals Group, The Sanwa Starch Co., Ltd., Bonumose LLC, Samyang Corporation, Matsutani Chemical Industry Co., Ltd., Sweet Cures, and Ingredion Incorporated.

Key players are engaged in several activities in order to strengthen its market position. For instance, in 2021, American Sugar Refining invested in Bonumose, Inc. for producing and commercialising tagatose and allulose. Bonumose, Inc. will focus on production of tagatose and allulose and focus on developing R&D pipeline.
 

Frequently Asked Question(FAQ) :

The market for rare sugar in Europe attained USD 200 million in annual revenue in 2019 and will record a growth rate of 3.5% up to 2026 due to increasing consumer awareness regarding the use of sugar alternatives.
Europe market share from the allulose product segment is anticipated to strike a growth of over 6.5% through 2026 owing to their increasing adoption in food applications as a sugar alternative.
The demand for dietary supplements will reach a significant share in the next few years driven by the rising consumer awareness and the higher number of individuals suffering from diabetes in the U.K.
Douglas Laboratories Europe, DuPont de Nemours, Inc., Tate & Lyle, Nutraceuticals Group, The Sanwa Starch Co., and Bonumose are prominent companies offering rare sugar products in the region.

Premium Report

Have questions?
  • Inquire Before Buying
  • Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

     1-800-986-6917

     [email protected]